Came across this in a Sanford Health Compliance Newsletter:
1. GlaxoSmithKline, $750 million for selling contaminated drugs to government health programs.
2. Allergan, $600 million for illegally marketing Botox and for paying kickbacks to prescribing physicians.
3. AstraZeneca, $520 million for illegally marketing Seroquel and for paying kickbacks to prescribing physicians.
4. Novartis Pharmaceuticals, $422.5 million for illegally marketing Trileptal and other drugs and for paying kickbacks to prescribing physicians.
5. Forest Pharmaceuticals, $313 million for paying kickbacks to prescribing physicians.
6. A tie: Roxane Laboratories, $280 million and Dey, Inc., $280 million for fraudulently inflating drug prices through an Average Wholesale Pricing (AWP) methodology ("AWP" has been dubbed as an acronym for "Ain't What's Paid").
7. Elan Corporation, $214.5 million for illegally marketing Zonegran.
8. Abbott Laboratories, Inc., $126.5 million for a similar fraudulent AWP methodology.
9. Health Alliance of Greater Cincinnati, $108 million for paying kickbacks to physicians for referring cardiac patients to hospitals.
10. Kos Pharmaceuticals, $41 million for illegally marketing Advicor and for paying kickbacks to prescribing physicians.
No comments:
Post a Comment